Home Podcasts Deep Margin
Deep Margin

Deep Margin

Dr Ben O'Leary and Dr Will Ince 22 episodes Latest May 31, 2026

A podcast dedicated to head and neck oncology, featuring conversations about cancer from the collar up. Hosted by Dr Ben O'Leary and Dr Will Ince, it covers topics related to the diagnosis, treatment, and research of head and neck cancers.

Episodes

Episode 21: Alan Ho live (post hoc) from the Multidisciplinary Head and Neck Cancers Symposium May 31, 2026 00:39:56 Alan Ho, Medical oncologist at MSKCC talks us through his work around Ozuriftamab Vedotin (Oz-V) and other ADC approaches. Ben criticises Will's combination approaches.
Episode 20: PAPER OF THE MONTH Nadeem Riaz talks us through cellular mechanisms of resistance, cluster f**ks and all the ecosystem. May 17, 2026 00:46:35 Nadeem Riaz directs the Precision Radiotherapy Initiative and leads a multidisciplinary research lab at the intersection of the DNA damage response and anti-tumor immunity. He talks us through his important paper examining mechanisms of resistance and some of the pitfalls of academia.
Episode 19: NIVOPOSTOP - nivolumab post op - a GORTEC triump with Yungan Tao May 11, 2026 00:38:14 Yungan Tao President-Elect GORTEC, and Radiation Oncologist in Head and Neck cancer at Institut Gustave-Roussy talks us through the NICOPOSTOP trial. Will risks diplomatic incidents and out European tour continues.
Episode 18: Our man in Denmark: Jeppe Friborg talks us through DAHANCA/Vores mand i Danmark: Jeppe Friborg taler os gennem DAHANCA May 4, 2026 00:38:38 The Danish Head and Neck Cancer (DAHANCA) group was established in 1976 as a working group by the Danish Society for Head and Neck Oncology. Since it has gone from strength to strength and continues to pioneer cooperative group research on a national scale! Current head Jeppe Friborg talks us through their up and coming work. Den danske gruppe for hoved- og halskræft (DAHANCA) blev etableret i 197
Episode 16: PAPER OF THE MONTH ALERT! Immune boost HPV with Mr Meta-Analysis himself Pr Pierre Blanchard Apr 20, 2026 00:42:55 Pierre Blanchard, Professor at Gustave Roussy and Editor of Radiotherapy and Oncology 'the green journal' joins us to discuss his recent trial
Episode 17: Nabil Saba talks us through sinonasal cancer Apr 20, 2026 00:50:57 Professor and Vice-chair of Hematology and Medical Oncology, and Professor of Otolaryngology at the Winship Cancer Institute at the Emory University School of Medicine in Atlanta, Georgia. He talks us through sinonasal histologies . Ben refers Will to social services.
Episode 15: Don't mention the 'P' word; long term functional outcomes with Professor Kate Hutcheson Apr 12, 2026 00:50:25 Superstar Kate Hutcheson, Professor in the  Department of Head and Neck Surgery at The University of Texas MD Anderson  Cancer Center. and Director of Speech Pathology and Audiology talks to us about long term outcomes and examines Will's literacy.
Episode 14 [PART 1] : ding ding round 2 in the red corner it's Chris Holsinger live with the E3311 trial and TORS adventures Apr 3, 2026 00:31:10 Chris Holsinger from Stanford gets grilled by Ben and Will on TORS history in this part 1/2 episode.
Episode 13: Ding Ding: TORS round 1 - the blue corner we have Professor David Palma talking about RT Mar 2, 2026 00:42:07 We talk ORATOR, ORATOR 2 and the genesis of evidence in TORS!
Episode 12: The Nasopharyngeal Gardener talks ctDNA with Dr Melvin Chua Feb 22, 2026 00:38:46 Melvin Chua joins the deeply marginal crowd to talk EBV ctDNA, its clinical use, science, gardening and islands.
Episode 11: Radiotherapy Revolutions with Professor Chris Nutting Feb 16, 2026 00:37:32 Chris Nutting, Professor of Radiotherapy and leader on many pivotal trials at the ICR joins us to talk through the past 25 years of radiotherapy advances and the data underpinning these. We talk about the future and Will has some technical difficulties so there is less nonsense than usual!
Episode 10: The Rockstar talks ctDNA with Dr Glenn Hanna Feb 9, 2026 00:53:25 Dr Glenn Hanna, Director of the Center for Cancer Therapeutic Innovation (CCTI) at Dana Faber Cancer Insitute joins us for our 10th episode and it's a cracker; Glenn talks us through the finer points of ctDNA, MRD and what the future holds for this exciting space.  

Recommended

Playing